CSF levels of hypocretin-1 (orexin-A) peak during early infancy in humans.
about
Evaluation of the potential effects of AS03-adjuvanted A(H1N1)pdm09 vaccine administration on the central nervous system of non-primed and A(H1N1)pdm09-primed cotton ratsInnervation of ventricular and periventricular brain compartments.High prevalence of precocious puberty and obesity in childhood narcolepsy with cataplexyA unified survival theory of the functioning of the hypocretinergic system.The emerging role of hypocretin (orexin-A) in the developing central nervous system.Anatomical and electrophysiological development of the hypothalamic orexin neurons from embryos to neonates.Orexinergic Modulation of Spinal Motor Activity in the Neonatal Mouse Spinal Cord
P2860
Q30392931-D34726E4-F2F0-4F65-84DE-C50B3FBD3E3BQ36019882-6AFF1497-1332-4099-9D8B-DCD28C01028DQ36526451-38C02127-17C9-49EF-9746-AE7C90BC2FF2Q38103817-6F1FA462-50BB-47B3-8F20-BBA37B66E198Q40127051-29EAAA23-1F1E-4146-A1C4-3287A6CC8FD7Q47721412-C13DDC17-9968-4813-A1D4-EB99912DBB9CQ58699595-507109B1-97EA-45E8-8612-4469DE1BA54D
P2860
CSF levels of hypocretin-1 (orexin-A) peak during early infancy in humans.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
CSF levels of hypocretin-1 (orexin-A) peak during early infancy in humans.
@en
type
label
CSF levels of hypocretin-1 (orexin-A) peak during early infancy in humans.
@en
prefLabel
CSF levels of hypocretin-1 (orexin-A) peak during early infancy in humans.
@en
P2093
P2860
P356
P1433
P1476
CSF levels of hypocretin-1 (orexin-A) peak during early infancy in humans.
@en
P2093
Irina Shors
Michael S Schimmel
P2860
P304
P356
10.5665/SLEEP.1618
P577
2012-02-01T00:00:00Z